1	the primary study cohort will include all infant from sckp who have begin their primary course of vaccine with pediarix co-administered with prevnar and for whom at least one dose of pediarix be administer prior to the infant 's 9-month birthday and safety follow-up information be available|prevnar[141,148]||||||||||798236|798220|streptococcus pneumoniae serotype 14 capsular antigen diphtheria crm197 protein conjugate vaccine
1	the primary study cohort will include all infant from sckp who have begin their primary course of vaccine with pediarix co-administered with prevnar and for whom at least one dose of pediarix be administer prior to the infant 's 9-month birthday and safety follow-up information be available|pediarix[111,119]|||||||||C1170508|352877|763096|poliovirus vaccine inactivated, type 1 (mahoney)
1	the primary study cohort will include all infant from sckp who have begin their primary course of vaccine with pediarix co-administered with prevnar and for whom at least one dose of pediarix be administer prior to the infant 's 9-month birthday and safety follow-up information be available|vaccine[98,105]||||||||||11094|11094|vaccine
1	the primary study cohort will include all infant from sckp who have begin their primary course of vaccine with pediarix co-administered with prevnar and for whom at least one dose of pediarix be administer prior to the infant 's 9-month birthday and safety follow-up information be available|pediarix[183,191]|||||||||C1170508|352877|763096|poliovirus vaccine inactivated, type 1 (mahoney)
